Skip to main content
Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
2.460
+0.100 (4.24%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Rapid Micro Biosystems Revenue

In the year 2025, Rapid Micro Biosystems had annual revenue of $33.59M with 19.74% growth. Rapid Micro Biosystems had revenue of $11.28M in the quarter ending December 31, 2025, with 37.28% growth.

Revenue (ttm)
$33.59M
Revenue Growth
+19.74%
P/S Ratio
3.35
Revenue / Employee
$196,415
Employees
171
Market Cap
112.59M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202533.59M5.54M19.74%
Dec 31, 202428.05M5.53M24.57%
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.15M44.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Treace Medical Concepts 212.69M
Neuronetics 149.16M
Xtant Medical Holdings 133.93M
Outset Medical 119.48M
Owlet 105.71M
AVITA Medical 71.61M
MaxCyte 33.03M
QT Imaging Holdings 18.93M
Revenue Rankings

RPID News

More News